Tuesday, April 22, 2025
Facebook Linkedin Twitter
HomeTagsBiocytogen

Biocytogen

Biotechnology

Biocytogen Announces Adcendo ApS Exercises Antibody Option

News Desk -
Biocytogen Pharmaceuticals Co., Ltd., a global biotech company focusing on the discovery of novel antibody/ADC therapeutics, announced that Adcendo ApS ("Adcendo"), a biotech company...
Biotechnology

Biocytogen Signs RenMab/RenLite Licensing Agreement with BeiGene

PR Newswire -
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. ("Biocytogen") reached an agreement with BeiGene (Beijing) Co., Ltd. for licensing Biocytogen's fully human antibody RenMab/RenLite mice platforms to...
Biotechnology

Biocytogen/Eucure Biopharma Announce the Completion of First Patient Dosing for Phase II Clinical Trial of YH003 in Australia

PR Newswire -
Eucure Biopharma, a wholly owned subsidiary of Biocytogen, announced the first patient dosing for a phase II clinical trial of YH003 (anti-CD40 monoclonal antibody,...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics

Load more
ReadMagazine © | All rights reserved |Contact Us | Privacy Policy| Become A Guest Writer | Advertise with Us